These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 3335175)

  • 1. Inotropic therapy for cardiac failure associated with acute myocardial infarction.
    Roberts R
    Chest; 1988 Jan; 93(1 Suppl):22S-24S. PubMed ID: 3335175
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of diuretics and inotropic therapy in failure associated with myocardial infarction.
    Roberts R
    Arch Int Physiol Biochim; 1984 Nov; 92(4):S33-48. PubMed ID: 6085238
    [No Abstract]   [Full Text] [Related]  

  • 3. Congestive heart failure.
    Ruggie N
    Med Clin North Am; 1986 Jul; 70(4):829-51. PubMed ID: 3012226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heart failure and acute myocardial infarct. Current treatment].
    Bernard R; Renard M
    Bull Mem Acad R Med Belg; 1983; 138(11):534-43. PubMed ID: 6679446
    [No Abstract]   [Full Text] [Related]  

  • 5. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiological bases and therapeutic uses of inodilator drugs].
    Costa R; De Marino V; Marino A
    Clin Ter; 1991 Jan; 136(2):85-94. PubMed ID: 1827377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
    Verma SP; Silke B; Reynolds GW; Richmond A; Taylor SH
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):24-33. PubMed ID: 1375684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of heart failure in children].
    Pipitone S; Manetti A
    G Ital Cardiol; 1995 Nov; 25(11):1485-90. PubMed ID: 8682250
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of intravenous amrinone on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine.
    Tanaka K; Takano T; Seino Y
    Jpn Circ J; 1986 Jul; 50(7):652-8. PubMed ID: 3773231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
    Uretsky BF
    Postgrad Med J; 1986 Jun; 62(728):585-92. PubMed ID: 2946034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-digitalic cardiac inotropic agents].
    Méndez R
    Arch Inst Cardiol Mex; 1981; 51(3):201-5. PubMed ID: 7283531
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart failure after Caesarean section for twin delivery.
    Crivellari M; Bove T; Landoni G; Zangrillo A
    Eur J Anaesthesiol; 2004 Dec; 21(12):986-8. PubMed ID: 15719865
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of congestive heart failure in patients with acute myocardial infarction.
    Genton R; Jaffe AS
    JAMA; 1986 Nov; 256(18):2556-60. PubMed ID: 3773157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of new inotropic agents in the treatment of acute cardiac failure].
    Dhainaut JF
    Ann Fr Anesth Reanim; 1988; 7(2):97-104. PubMed ID: 2896479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of amrinone, dobutamine and dopamine in the cardiac low output syndrome following open-heart surgery].
    Husedzinović I; Rumboldt Z; Ivancan V; Nikić N; Rudeź I; Biocina B; Sutlić Z
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():32-4. PubMed ID: 8649147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
    Buser PT; Wu SY; Parmley WW; Jasmin G; Wikman-Coffelt J
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):151-7. PubMed ID: 7786836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New positive inotropic drugs for the treatment of congestive heart failure.
    Sonnenblick EH; Mancini DM; LeJemtel TH
    Am J Cardiol; 1985 Jan; 55(2):41A-44A. PubMed ID: 2981465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
    Rudolph W; Dirschinger J
    Herz; 1981 Feb; 6(1):25-36. PubMed ID: 7216120
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
    Chatterjee K; De Marco T
    Med Clin North Am; 2003 Mar; 87(2):391-418. PubMed ID: 12693731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rational and irrational approach to the inotropic agent therapy of heart failure].
    Colombo F; Libretti A
    Clin Ter; 1988 Sep; 126(6):421-6. PubMed ID: 2974404
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.